Inhibitory Effect of AB-PINACA, Indazole Carboxamide Synthetic Cannabinoid, on Human Major Drug-Metabolizing Enzymes and Transporters

Indazole carboxamide synthetic cannabinoid, AB-PINACA, has been placed into Schedule I of the Controlled Substances Act by the US Drug Enforcement Administration since 2015. Despite the possibility of AB-PINACA exposure in drug abusers, the interactions between AB-PINACA and drug-metabolizing enzyme...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Pharmaceutics
Päätekijät: Park, Eun Jeong, Park, Ria, Jeon, Ji-Hyeon, Cho, Yong-Yeon, Lee, Joo Young, Kang, Han Chang, Song, Im-Sook, Lee, Hye Suk
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI 2020
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7692329/
https://ncbi.nlm.nih.gov/pubmed/33138123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics12111036
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia